Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PMF scoring revisited.

Ingo Muegge1

  • 1Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877-0368, USA. imugge@rdg.boehringer-ingelheim.com

Journal of Medicinal Chemistry
|September 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How does machine learning augment alchemical binding free energy calculations?

Future medicinal chemistry·2025
Same author

Perspectives on current approaches to virtual screening in drug discovery.

Expert opinion on drug discovery·2024
Same author

Advances in virtual screening.

Drug discovery today. Technologies·2024
Same author

Prediction of Human Clearance Using In Silico Models with Reduced Bias.

Molecular pharmaceutics·2024
Same author

Recent Advances in Alchemical Binding Free Energy Calculations for Drug Discovery.

ACS medicinal chemistry letters·2023
Same author

How do we further enhance 2D fingerprint similarity searching for novel drug discovery?

Expert opinion on drug discovery·2022
Same journal

Small Molecules in Development for the Treatment of Sepsis: Insights into Drug Targets and Molecular Mechanisms.

Journal of medicinal chemistry·2026
Same journal

Isofagomine Derivatives as TcdB Glucosyltransferase Inhibitors.

Journal of medicinal chemistry·2026
Same journal

The One-Step Incorporation of Boron-10 Atom into Prostate Cancer-Targeted Fluorophores for Visualizing In Vivo Boron-10 Delivery and Intratumoral Distribution with Cellular Resolution.

Journal of medicinal chemistry·2026
Same journal

Design and Evaluation of Conformationally Locked Indole-Carboxylic Acids as Selective THRβ Agonists against MASH.

Journal of medicinal chemistry·2026
Same journal

Drug Screening of Nitroreductase Modulators Using an Atomic-Engineered Activatable Fluorescent Probe for Tumor Imaging.

Journal of medicinal chemistry·2026
Same journal

Reprogramming Acetaminophen Metabolism via Amide-to-Thioamide Modification to Prevent Drug-Induced Liver Injury.

Journal of medicinal chemistry·2026
See all related articles

The updated PMF04 scoring function, based on a tenfold larger dataset, improves protein-ligand binding affinity prediction. This enhanced potential of mean force (PMF) scoring now includes metal ions and halogens for better accuracy.

Area of Science:

  • Computational chemistry
  • Structural biology
  • Drug discovery

Background:

  • Knowledge-based scoring functions are crucial for predicting protein-ligand binding affinities.
  • The availability of extensive protein-ligand complex data necessitates re-evaluating and updating scoring functions.
  • Previous potential of mean force (PMF) scoring (PMF99) relied on a smaller dataset.

Purpose of the Study:

  • To develop an improved knowledge-based scoring function (PMF04) for protein-ligand binding affinity prediction.
  • To leverage a significantly larger dataset of protein-ligand complexes for more robust statistical analysis.
  • To incorporate potentials for metal ions and halogens into the scoring function.

Main Methods:

  • Derived updated potentials of mean force (PMF) using an expanded dataset of 7152 protein-ligand complexes from the Protein Data Bank (PDB).

Related Experiment Videos

  • Developed new potentials for metal ions and statistically significant potentials for halogens.
  • Compared the scoring accuracy of the new PMF04 function against the previous PMF99 function using established test sets and the PDBbind database.

    • Main Results:

    • The PMF04 scoring function, based on a 10-fold larger dataset than PMF99, demonstrates improved scoring accuracy.
    • Potentials for metal ions were derived for the first time, and potentials for halogens were included due to statistical significance.
    • Testing on the PDBbind database highlighted both the strengths and current limitations of the PMF scoring approach.

    Conclusions:

    • The PMF04 scoring function represents a significant advancement over PMF99 due to its larger statistical basis.
    • The inclusion of metal ions and halogens enhances the applicability of PMF scoring in drug discovery.
    • Further development is needed to address the limitations of current PMF scoring methods for large-scale applications.